Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacological Modulation of Belief Salience

NCT03754062 is registered in ClinicalTrials.gov with King's College London as lead sponsor.

NCT NCT03754062
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03754062 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacological Modulation of Belief Salience
Lead sponsor
King's College London
Phase
Phase 1
Overall status
Completed
Start date
June 1, 2017
Completion date
September 1, 2019
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

haloperidol, l-dopa, placebo